What is OSR Holdings Inc?
, a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 7.06M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.